Filing Flows › Strategy (MSTR) › Stock forecast & fair value
Strategy (MSTR) stock forecast and fair value
Strategy (MSTR) trades at $151.11. 15 analysts' median price target is $215.00 (+42%), from $165.00 to $435.00. Across 8 valuation methods the middle fair value is $72.16 (-52%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| EV/Sales vs peers, weighted | −$4.44 | −$2.26 | $1.74 | -101% |
| Residual income | −$18.39 | −$18.72 | −$19.05 | -112% |
| Analysts' price targets | $165.00 | $233.27 | $435.00 | +54% |
| Tangible book (asset value) | $57.72 | $72.16 | $72.16 | -52% |
| Stage-weighted value (decline / turnaround) | $57.72 | $72.16 | $72.16 | -52% |
| Combined forecast (3 months) | $123.73 | $157.13 | $194.68 | +4% |
| Schwartz–Moon simulation (cash can run out) | $0.00 | $0.14 | $0.00 | -100% |
| EV/Sales fair multiple (multi-factor fit) | −$8.78 | −$7.44 | −$4.57 | -105% |
Strategy's latest quarter
Strategy, Q3 2026: revenue $125M (-2% year over year), net earnings $19.5B, operating cash flow $4.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for MSTR stock?
The median of 15 analysts' 12-month targets is $215.00, +42% from $151.11; the range is $165.00 to $435.00. The average rating is strong buy.
What is Strategy's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between −$18.72 and $233.27, with a middle value of $72.16 against a price of $151.11. Each method's assumptions are on the page.
Does Strategy usually beat earnings estimates?
It beat the consensus EPS estimate in 20% of the quarters on record.
Is MSTR stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.